Achieve Life Sciences (NASDAQ:ACHV – Get Free Report) and Glass House Brands (OTCMKTS:GLASF – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.
Earnings and Valuation
This table compares Achieve Life Sciences and Glass House Brands”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Achieve Life Sciences | N/A | N/A | -$54.65 million | ($1.55) | -5.23 |
| Glass House Brands | N/A | N/A | N/A | N/A | N/A |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Achieve Life Sciences | 1 | 0 | 5 | 2 | 3.00 |
| Glass House Brands | 0 | 1 | 0 | 0 | 2.00 |
Achieve Life Sciences currently has a consensus target price of $15.00, indicating a potential upside of 85.19%. Given Achieve Life Sciences’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Achieve Life Sciences is more favorable than Glass House Brands.
Insider and Institutional Ownership
33.5% of Achieve Life Sciences shares are owned by institutional investors. 1.8% of Achieve Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Achieve Life Sciences and Glass House Brands’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Achieve Life Sciences | N/A | -511.12% | -82.35% |
| Glass House Brands | N/A | N/A | N/A |
Summary
Achieve Life Sciences beats Glass House Brands on 6 of the 8 factors compared between the two stocks.
About Achieve Life Sciences
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
About Glass House Brands
Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. It cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. The company also owns and operates retail cannabis stores. In addition, it offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company offers its cannabis products under the Glass House Farms, FIELD, Forbidden Flowers, PLUS, Mama Sue, Allswell, and REEFORM brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.
Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
